J CANCER RES CLIN 润色咨询

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

出版年份：1979 年文章数：3146 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：2.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=588890, encodeId=fb3058889093, content=通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/28/a5fe04f5f79e7eaa02a969e1db5d9cfa.jpg, createdBy=aaa45315037, createdName=学海无涯123, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602329, encodeId=6e406023297c, content=请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/b4f0d751268e44e3a8cb4f42e09324f5/2450ad5bc2e449b79c8da57d5f6d1ac1.jpg, createdBy=66d25241559, createdName=147c079dm30(暂无昵称), createdTime=Mon Jun 15 20:02:46 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799576, encodeId=8c71e99576b3, content=投稿8天被拒搞，没有给任何评价，伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/40807ce1b45849feb595a4fd58bc8cce/bae07d646db64f6ba1fc10d2dc5e0bb3.jpg, createdBy=0bdc5296801, createdName=HahaHelloHa, createdTime=Wed Jun 24 16:39:19 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578226, encodeId=85ae5e822622, content=要版面费吗？ <span class="quote">闹闹naonao 2019-10-17 发表::<br>请问需要提供的原始数据都是关于什么实验的呢？ </span><span class="quote">闹闹naonao 2019-10-17 00:00:00 发表:<br>请问需要提供的原始数据都是关于什么实验的呢？ </span>, beContent=闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LZ3kWE6hVO0xjMAhLBocM81brfTB5UBBQ9j4ibbfkFw68aiaqI55zp3WicibzLB7v18d1wSFEYDpsk4qH9ZHFc9Ouw/132, createdBy=0dc52359627, createdName=奔跑的蜗牛222, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587274, encodeId=27f058e27431, content=审稿速度怎么样，一审多久给回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/22/16fe440149131866dcceb2ab3e224120.jpg, createdBy=71912410689, createdName=仰望摩天轮, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588489, encodeId=19fe58848918, content=请问这个杂志如果没送审就被拒的话大概花多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590104, encodeId=1a61590104f1, content=有人知道那个非oa在哪里选吗？为什么我没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde95319819, createdName=2564, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信<br>经验分享：过程还是非常快的，希望期刊后面越来越好<br>Publishing and rights<br>Submission status Date<br>Publishing and rights complete<br>07 May 2024<br>Submission is in publishing and rights<br>15 Apr 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>03 Apr 2024<br>Submission under peer review<br>28 Mar 2024<br>Submission passed technical check<br>28 Mar 2024<br>Revision received<br>27 Mar 2024<br>Submission under peer review<br>19 Feb 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>19 Feb 2024<br>Submission is under technical check<br>18 Feb 2024<br>Submission received<br>Submission status Date<br>Submission received<br>18 Feb 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。<br>Version 1 (private)<br>received 11 Mar, 2024<br><br> Reviews received<br> Received 24 Apr, 2024<br> Reviewers agreed<br> On 27 Mar, 2024<br> Reviewers invited<br> Invitations sent on 21 Mar, 2024<br> Submission checks complete<br> On 13 Mar, 2024<br> Editor assigned<br> On 13 Mar, 2024<br> First submitted to Journal of Cancer Research and Clinical Oncology<br> On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198633, encodeId=5897219863300, content=审稿速度:2.0<br>偏重的研究方向：免疫;肿瘤;生信<br>经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2458147977, createdName=ms7000001719461797, createdTime=Mon Apr 15 16:42:11 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆)]
    2020-04-15 学海无涯123

    通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=588890, encodeId=fb3058889093, content=通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/28/a5fe04f5f79e7eaa02a969e1db5d9cfa.jpg, createdBy=aaa45315037, createdName=学海无涯123, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602329, encodeId=6e406023297c, content=请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/b4f0d751268e44e3a8cb4f42e09324f5/2450ad5bc2e449b79c8da57d5f6d1ac1.jpg, createdBy=66d25241559, createdName=147c079dm30(暂无昵称), createdTime=Mon Jun 15 20:02:46 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799576, encodeId=8c71e99576b3, content=投稿8天被拒搞，没有给任何评价，伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/40807ce1b45849feb595a4fd58bc8cce/bae07d646db64f6ba1fc10d2dc5e0bb3.jpg, createdBy=0bdc5296801, createdName=HahaHelloHa, createdTime=Wed Jun 24 16:39:19 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578226, encodeId=85ae5e822622, content=要版面费吗？ <span class="quote">闹闹naonao 2019-10-17 发表::<br>请问需要提供的原始数据都是关于什么实验的呢？ </span><span class="quote">闹闹naonao 2019-10-17 00:00:00 发表:<br>请问需要提供的原始数据都是关于什么实验的呢？ </span>, beContent=闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LZ3kWE6hVO0xjMAhLBocM81brfTB5UBBQ9j4ibbfkFw68aiaqI55zp3WicibzLB7v18d1wSFEYDpsk4qH9ZHFc9Ouw/132, createdBy=0dc52359627, createdName=奔跑的蜗牛222, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587274, encodeId=27f058e27431, content=审稿速度怎么样，一审多久给回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/22/16fe440149131866dcceb2ab3e224120.jpg, createdBy=71912410689, createdName=仰望摩天轮, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588489, encodeId=19fe58848918, content=请问这个杂志如果没送审就被拒的话大概花多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590104, encodeId=1a61590104f1, content=有人知道那个非oa在哪里选吗？为什么我没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde95319819, createdName=2564, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信<br>经验分享：过程还是非常快的，希望期刊后面越来越好<br>Publishing and rights<br>Submission status Date<br>Publishing and rights complete<br>07 May 2024<br>Submission is in publishing and rights<br>15 Apr 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>03 Apr 2024<br>Submission under peer review<br>28 Mar 2024<br>Submission passed technical check<br>28 Mar 2024<br>Revision received<br>27 Mar 2024<br>Submission under peer review<br>19 Feb 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>19 Feb 2024<br>Submission is under technical check<br>18 Feb 2024<br>Submission received<br>Submission status Date<br>Submission received<br>18 Feb 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。<br>Version 1 (private)<br>received 11 Mar, 2024<br><br> Reviews received<br> Received 24 Apr, 2024<br> Reviewers agreed<br> On 27 Mar, 2024<br> Reviewers invited<br> Invitations sent on 21 Mar, 2024<br> Submission checks complete<br> On 13 Mar, 2024<br> Editor assigned<br> On 13 Mar, 2024<br> First submitted to Journal of Cancer Research and Clinical Oncology<br> On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198633, encodeId=5897219863300, content=审稿速度:2.0<br>偏重的研究方向：免疫;肿瘤;生信<br>经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2458147977, createdName=ms7000001719461797, createdTime=Mon Apr 15 16:42:11 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆)]
    2020-06-15 147c079dm30(暂无昵称)

    请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=588890, encodeId=fb3058889093, content=通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/28/a5fe04f5f79e7eaa02a969e1db5d9cfa.jpg, createdBy=aaa45315037, createdName=学海无涯123, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602329, encodeId=6e406023297c, content=请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/b4f0d751268e44e3a8cb4f42e09324f5/2450ad5bc2e449b79c8da57d5f6d1ac1.jpg, createdBy=66d25241559, createdName=147c079dm30(暂无昵称), createdTime=Mon Jun 15 20:02:46 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799576, encodeId=8c71e99576b3, content=投稿8天被拒搞，没有给任何评价，伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/40807ce1b45849feb595a4fd58bc8cce/bae07d646db64f6ba1fc10d2dc5e0bb3.jpg, createdBy=0bdc5296801, createdName=HahaHelloHa, createdTime=Wed Jun 24 16:39:19 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578226, encodeId=85ae5e822622, content=要版面费吗？ <span class="quote">闹闹naonao 2019-10-17 发表::<br>请问需要提供的原始数据都是关于什么实验的呢？ </span><span class="quote">闹闹naonao 2019-10-17 00:00:00 发表:<br>请问需要提供的原始数据都是关于什么实验的呢？ </span>, beContent=闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LZ3kWE6hVO0xjMAhLBocM81brfTB5UBBQ9j4ibbfkFw68aiaqI55zp3WicibzLB7v18d1wSFEYDpsk4qH9ZHFc9Ouw/132, createdBy=0dc52359627, createdName=奔跑的蜗牛222, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587274, encodeId=27f058e27431, content=审稿速度怎么样，一审多久给回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/22/16fe440149131866dcceb2ab3e224120.jpg, createdBy=71912410689, createdName=仰望摩天轮, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588489, encodeId=19fe58848918, content=请问这个杂志如果没送审就被拒的话大概花多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590104, encodeId=1a61590104f1, content=有人知道那个非oa在哪里选吗？为什么我没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde95319819, createdName=2564, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信<br>经验分享：过程还是非常快的，希望期刊后面越来越好<br>Publishing and rights<br>Submission status Date<br>Publishing and rights complete<br>07 May 2024<br>Submission is in publishing and rights<br>15 Apr 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>03 Apr 2024<br>Submission under peer review<br>28 Mar 2024<br>Submission passed technical check<br>28 Mar 2024<br>Revision received<br>27 Mar 2024<br>Submission under peer review<br>19 Feb 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>19 Feb 2024<br>Submission is under technical check<br>18 Feb 2024<br>Submission received<br>Submission status Date<br>Submission received<br>18 Feb 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。<br>Version 1 (private)<br>received 11 Mar, 2024<br><br> Reviews received<br> Received 24 Apr, 2024<br> Reviewers agreed<br> On 27 Mar, 2024<br> Reviewers invited<br> Invitations sent on 21 Mar, 2024<br> Submission checks complete<br> On 13 Mar, 2024<br> Editor assigned<br> On 13 Mar, 2024<br> First submitted to Journal of Cancer Research and Clinical Oncology<br> On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198633, encodeId=5897219863300, content=审稿速度:2.0<br>偏重的研究方向：免疫;肿瘤;生信<br>经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2458147977, createdName=ms7000001719461797, createdTime=Mon Apr 15 16:42:11 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆)]
    2020-06-24 HahaHelloHa

    投稿8天被拒搞，没有给任何评价，伤心

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=588890, encodeId=fb3058889093, content=通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/28/a5fe04f5f79e7eaa02a969e1db5d9cfa.jpg, createdBy=aaa45315037, createdName=学海无涯123, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602329, encodeId=6e406023297c, content=请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/b4f0d751268e44e3a8cb4f42e09324f5/2450ad5bc2e449b79c8da57d5f6d1ac1.jpg, createdBy=66d25241559, createdName=147c079dm30(暂无昵称), createdTime=Mon Jun 15 20:02:46 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799576, encodeId=8c71e99576b3, content=投稿8天被拒搞，没有给任何评价，伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/40807ce1b45849feb595a4fd58bc8cce/bae07d646db64f6ba1fc10d2dc5e0bb3.jpg, createdBy=0bdc5296801, createdName=HahaHelloHa, createdTime=Wed Jun 24 16:39:19 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578226, encodeId=85ae5e822622, content=要版面费吗？ <span class="quote">闹闹naonao 2019-10-17 发表::<br>请问需要提供的原始数据都是关于什么实验的呢？ </span><span class="quote">闹闹naonao 2019-10-17 00:00:00 发表:<br>请问需要提供的原始数据都是关于什么实验的呢？ </span>, beContent=闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LZ3kWE6hVO0xjMAhLBocM81brfTB5UBBQ9j4ibbfkFw68aiaqI55zp3WicibzLB7v18d1wSFEYDpsk4qH9ZHFc9Ouw/132, createdBy=0dc52359627, createdName=奔跑的蜗牛222, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587274, encodeId=27f058e27431, content=审稿速度怎么样，一审多久给回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/22/16fe440149131866dcceb2ab3e224120.jpg, createdBy=71912410689, createdName=仰望摩天轮, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588489, encodeId=19fe58848918, content=请问这个杂志如果没送审就被拒的话大概花多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590104, encodeId=1a61590104f1, content=有人知道那个非oa在哪里选吗？为什么我没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde95319819, createdName=2564, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信<br>经验分享：过程还是非常快的，希望期刊后面越来越好<br>Publishing and rights<br>Submission status Date<br>Publishing and rights complete<br>07 May 2024<br>Submission is in publishing and rights<br>15 Apr 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>03 Apr 2024<br>Submission under peer review<br>28 Mar 2024<br>Submission passed technical check<br>28 Mar 2024<br>Revision received<br>27 Mar 2024<br>Submission under peer review<br>19 Feb 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>19 Feb 2024<br>Submission is under technical check<br>18 Feb 2024<br>Submission received<br>Submission status Date<br>Submission received<br>18 Feb 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。<br>Version 1 (private)<br>received 11 Mar, 2024<br><br> Reviews received<br> Received 24 Apr, 2024<br> Reviewers agreed<br> On 27 Mar, 2024<br> Reviewers invited<br> Invitations sent on 21 Mar, 2024<br> Submission checks complete<br> On 13 Mar, 2024<br> Editor assigned<br> On 13 Mar, 2024<br> First submitted to Journal of Cancer Research and Clinical Oncology<br> On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198633, encodeId=5897219863300, content=审稿速度:2.0<br>偏重的研究方向：免疫;肿瘤;生信<br>经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2458147977, createdName=ms7000001719461797, createdTime=Mon Apr 15 16:42:11 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆)]
    2019-10-21 奔跑的蜗牛222

    要版面费吗？ 闹闹naonao 2019-10-17 发表::
    请问需要提供的原始数据都是关于什么实验的呢？     闹闹naonao 2019-10-17 00:00:00 发表:
    请问需要提供的原始数据都是关于什么实验的呢？

    闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=588890, encodeId=fb3058889093, content=通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/28/a5fe04f5f79e7eaa02a969e1db5d9cfa.jpg, createdBy=aaa45315037, createdName=学海无涯123, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602329, encodeId=6e406023297c, content=请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/b4f0d751268e44e3a8cb4f42e09324f5/2450ad5bc2e449b79c8da57d5f6d1ac1.jpg, createdBy=66d25241559, createdName=147c079dm30(暂无昵称), createdTime=Mon Jun 15 20:02:46 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799576, encodeId=8c71e99576b3, content=投稿8天被拒搞，没有给任何评价，伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/40807ce1b45849feb595a4fd58bc8cce/bae07d646db64f6ba1fc10d2dc5e0bb3.jpg, createdBy=0bdc5296801, createdName=HahaHelloHa, createdTime=Wed Jun 24 16:39:19 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578226, encodeId=85ae5e822622, content=要版面费吗？ <span class="quote">闹闹naonao 2019-10-17 发表::<br>请问需要提供的原始数据都是关于什么实验的呢？ </span><span class="quote">闹闹naonao 2019-10-17 00:00:00 发表:<br>请问需要提供的原始数据都是关于什么实验的呢？ </span>, beContent=闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LZ3kWE6hVO0xjMAhLBocM81brfTB5UBBQ9j4ibbfkFw68aiaqI55zp3WicibzLB7v18d1wSFEYDpsk4qH9ZHFc9Ouw/132, createdBy=0dc52359627, createdName=奔跑的蜗牛222, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587274, encodeId=27f058e27431, content=审稿速度怎么样，一审多久给回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/22/16fe440149131866dcceb2ab3e224120.jpg, createdBy=71912410689, createdName=仰望摩天轮, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588489, encodeId=19fe58848918, content=请问这个杂志如果没送审就被拒的话大概花多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590104, encodeId=1a61590104f1, content=有人知道那个非oa在哪里选吗？为什么我没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde95319819, createdName=2564, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信<br>经验分享：过程还是非常快的，希望期刊后面越来越好<br>Publishing and rights<br>Submission status Date<br>Publishing and rights complete<br>07 May 2024<br>Submission is in publishing and rights<br>15 Apr 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>03 Apr 2024<br>Submission under peer review<br>28 Mar 2024<br>Submission passed technical check<br>28 Mar 2024<br>Revision received<br>27 Mar 2024<br>Submission under peer review<br>19 Feb 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>19 Feb 2024<br>Submission is under technical check<br>18 Feb 2024<br>Submission received<br>Submission status Date<br>Submission received<br>18 Feb 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。<br>Version 1 (private)<br>received 11 Mar, 2024<br><br> Reviews received<br> Received 24 Apr, 2024<br> Reviewers agreed<br> On 27 Mar, 2024<br> Reviewers invited<br> Invitations sent on 21 Mar, 2024<br> Submission checks complete<br> On 13 Mar, 2024<br> Editor assigned<br> On 13 Mar, 2024<br> First submitted to Journal of Cancer Research and Clinical Oncology<br> On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198633, encodeId=5897219863300, content=审稿速度:2.0<br>偏重的研究方向：免疫;肿瘤;生信<br>经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2458147977, createdName=ms7000001719461797, createdTime=Mon Apr 15 16:42:11 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆)]
    2020-03-24 仰望摩天轮

    审稿速度怎么样，一审多久给回应

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=588890, encodeId=fb3058889093, content=通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/28/a5fe04f5f79e7eaa02a969e1db5d9cfa.jpg, createdBy=aaa45315037, createdName=学海无涯123, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602329, encodeId=6e406023297c, content=请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/b4f0d751268e44e3a8cb4f42e09324f5/2450ad5bc2e449b79c8da57d5f6d1ac1.jpg, createdBy=66d25241559, createdName=147c079dm30(暂无昵称), createdTime=Mon Jun 15 20:02:46 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799576, encodeId=8c71e99576b3, content=投稿8天被拒搞，没有给任何评价，伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/40807ce1b45849feb595a4fd58bc8cce/bae07d646db64f6ba1fc10d2dc5e0bb3.jpg, createdBy=0bdc5296801, createdName=HahaHelloHa, createdTime=Wed Jun 24 16:39:19 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578226, encodeId=85ae5e822622, content=要版面费吗？ <span class="quote">闹闹naonao 2019-10-17 发表::<br>请问需要提供的原始数据都是关于什么实验的呢？ </span><span class="quote">闹闹naonao 2019-10-17 00:00:00 发表:<br>请问需要提供的原始数据都是关于什么实验的呢？ </span>, beContent=闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LZ3kWE6hVO0xjMAhLBocM81brfTB5UBBQ9j4ibbfkFw68aiaqI55zp3WicibzLB7v18d1wSFEYDpsk4qH9ZHFc9Ouw/132, createdBy=0dc52359627, createdName=奔跑的蜗牛222, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587274, encodeId=27f058e27431, content=审稿速度怎么样，一审多久给回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/22/16fe440149131866dcceb2ab3e224120.jpg, createdBy=71912410689, createdName=仰望摩天轮, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588489, encodeId=19fe58848918, content=请问这个杂志如果没送审就被拒的话大概花多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590104, encodeId=1a61590104f1, content=有人知道那个非oa在哪里选吗？为什么我没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde95319819, createdName=2564, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信<br>经验分享：过程还是非常快的，希望期刊后面越来越好<br>Publishing and rights<br>Submission status Date<br>Publishing and rights complete<br>07 May 2024<br>Submission is in publishing and rights<br>15 Apr 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>03 Apr 2024<br>Submission under peer review<br>28 Mar 2024<br>Submission passed technical check<br>28 Mar 2024<br>Revision received<br>27 Mar 2024<br>Submission under peer review<br>19 Feb 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>19 Feb 2024<br>Submission is under technical check<br>18 Feb 2024<br>Submission received<br>Submission status Date<br>Submission received<br>18 Feb 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。<br>Version 1 (private)<br>received 11 Mar, 2024<br><br> Reviews received<br> Received 24 Apr, 2024<br> Reviewers agreed<br> On 27 Mar, 2024<br> Reviewers invited<br> Invitations sent on 21 Mar, 2024<br> Submission checks complete<br> On 13 Mar, 2024<br> Editor assigned<br> On 13 Mar, 2024<br> First submitted to Journal of Cancer Research and Clinical Oncology<br> On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198633, encodeId=5897219863300, content=审稿速度:2.0<br>偏重的研究方向：免疫;肿瘤;生信<br>经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2458147977, createdName=ms7000001719461797, createdTime=Mon Apr 15 16:42:11 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆)]
    2020-04-09 jiongjiong830

    请问这个杂志如果没送审就被拒的话大概花多长时间？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=588890, encodeId=fb3058889093, content=通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/28/a5fe04f5f79e7eaa02a969e1db5d9cfa.jpg, createdBy=aaa45315037, createdName=学海无涯123, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602329, encodeId=6e406023297c, content=请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/b4f0d751268e44e3a8cb4f42e09324f5/2450ad5bc2e449b79c8da57d5f6d1ac1.jpg, createdBy=66d25241559, createdName=147c079dm30(暂无昵称), createdTime=Mon Jun 15 20:02:46 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799576, encodeId=8c71e99576b3, content=投稿8天被拒搞，没有给任何评价，伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/40807ce1b45849feb595a4fd58bc8cce/bae07d646db64f6ba1fc10d2dc5e0bb3.jpg, createdBy=0bdc5296801, createdName=HahaHelloHa, createdTime=Wed Jun 24 16:39:19 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578226, encodeId=85ae5e822622, content=要版面费吗？ <span class="quote">闹闹naonao 2019-10-17 发表::<br>请问需要提供的原始数据都是关于什么实验的呢？ </span><span class="quote">闹闹naonao 2019-10-17 00:00:00 发表:<br>请问需要提供的原始数据都是关于什么实验的呢？ </span>, beContent=闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LZ3kWE6hVO0xjMAhLBocM81brfTB5UBBQ9j4ibbfkFw68aiaqI55zp3WicibzLB7v18d1wSFEYDpsk4qH9ZHFc9Ouw/132, createdBy=0dc52359627, createdName=奔跑的蜗牛222, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587274, encodeId=27f058e27431, content=审稿速度怎么样，一审多久给回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/22/16fe440149131866dcceb2ab3e224120.jpg, createdBy=71912410689, createdName=仰望摩天轮, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588489, encodeId=19fe58848918, content=请问这个杂志如果没送审就被拒的话大概花多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590104, encodeId=1a61590104f1, content=有人知道那个非oa在哪里选吗？为什么我没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde95319819, createdName=2564, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信<br>经验分享：过程还是非常快的，希望期刊后面越来越好<br>Publishing and rights<br>Submission status Date<br>Publishing and rights complete<br>07 May 2024<br>Submission is in publishing and rights<br>15 Apr 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>03 Apr 2024<br>Submission under peer review<br>28 Mar 2024<br>Submission passed technical check<br>28 Mar 2024<br>Revision received<br>27 Mar 2024<br>Submission under peer review<br>19 Feb 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>19 Feb 2024<br>Submission is under technical check<br>18 Feb 2024<br>Submission received<br>Submission status Date<br>Submission received<br>18 Feb 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。<br>Version 1 (private)<br>received 11 Mar, 2024<br><br> Reviews received<br> Received 24 Apr, 2024<br> Reviewers agreed<br> On 27 Mar, 2024<br> Reviewers invited<br> Invitations sent on 21 Mar, 2024<br> Submission checks complete<br> On 13 Mar, 2024<br> Editor assigned<br> On 13 Mar, 2024<br> First submitted to Journal of Cancer Research and Clinical Oncology<br> On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198633, encodeId=5897219863300, content=审稿速度:2.0<br>偏重的研究方向：免疫;肿瘤;生信<br>经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2458147977, createdName=ms7000001719461797, createdTime=Mon Apr 15 16:42:11 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆)]
    2020-05-02 2564

    有人知道那个非oa在哪里选吗？为什么我没有看到

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=588890, encodeId=fb3058889093, content=通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/28/a5fe04f5f79e7eaa02a969e1db5d9cfa.jpg, createdBy=aaa45315037, createdName=学海无涯123, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602329, encodeId=6e406023297c, content=请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/b4f0d751268e44e3a8cb4f42e09324f5/2450ad5bc2e449b79c8da57d5f6d1ac1.jpg, createdBy=66d25241559, createdName=147c079dm30(暂无昵称), createdTime=Mon Jun 15 20:02:46 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799576, encodeId=8c71e99576b3, content=投稿8天被拒搞，没有给任何评价，伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/40807ce1b45849feb595a4fd58bc8cce/bae07d646db64f6ba1fc10d2dc5e0bb3.jpg, createdBy=0bdc5296801, createdName=HahaHelloHa, createdTime=Wed Jun 24 16:39:19 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578226, encodeId=85ae5e822622, content=要版面费吗？ <span class="quote">闹闹naonao 2019-10-17 发表::<br>请问需要提供的原始数据都是关于什么实验的呢？ </span><span class="quote">闹闹naonao 2019-10-17 00:00:00 发表:<br>请问需要提供的原始数据都是关于什么实验的呢？ </span>, beContent=闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LZ3kWE6hVO0xjMAhLBocM81brfTB5UBBQ9j4ibbfkFw68aiaqI55zp3WicibzLB7v18d1wSFEYDpsk4qH9ZHFc9Ouw/132, createdBy=0dc52359627, createdName=奔跑的蜗牛222, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587274, encodeId=27f058e27431, content=审稿速度怎么样，一审多久给回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/22/16fe440149131866dcceb2ab3e224120.jpg, createdBy=71912410689, createdName=仰望摩天轮, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588489, encodeId=19fe58848918, content=请问这个杂志如果没送审就被拒的话大概花多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590104, encodeId=1a61590104f1, content=有人知道那个非oa在哪里选吗？为什么我没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde95319819, createdName=2564, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信<br>经验分享：过程还是非常快的，希望期刊后面越来越好<br>Publishing and rights<br>Submission status Date<br>Publishing and rights complete<br>07 May 2024<br>Submission is in publishing and rights<br>15 Apr 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>03 Apr 2024<br>Submission under peer review<br>28 Mar 2024<br>Submission passed technical check<br>28 Mar 2024<br>Revision received<br>27 Mar 2024<br>Submission under peer review<br>19 Feb 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>19 Feb 2024<br>Submission is under technical check<br>18 Feb 2024<br>Submission received<br>Submission status Date<br>Submission received<br>18 Feb 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。<br>Version 1 (private)<br>received 11 Mar, 2024<br><br> Reviews received<br> Received 24 Apr, 2024<br> Reviewers agreed<br> On 27 Mar, 2024<br> Reviewers invited<br> Invitations sent on 21 Mar, 2024<br> Submission checks complete<br> On 13 Mar, 2024<br> Editor assigned<br> On 13 Mar, 2024<br> First submitted to Journal of Cancer Research and Clinical Oncology<br> On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198633, encodeId=5897219863300, content=审稿速度:2.0<br>偏重的研究方向：免疫;肿瘤;生信<br>经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2458147977, createdName=ms7000001719461797, createdTime=Mon Apr 15 16:42:11 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆)]
    2024-05-23 1222c49dm85(暂无昵称) 来自新加坡

    偏重的研究方向：肿瘤;生信
    经验分享：过程还是非常快的，希望期刊后面越来越好
    Publishing and rights
    Submission status Date
    Publishing and rights complete
    07 May 2024
    Submission is in publishing and rights
    15 Apr 2024
    Peer review
    Submission status Date
    Submission accepted
    03 Apr 2024
    Submission under peer review
    28 Mar 2024
    Submission passed technical check
    28 Mar 2024
    Revision received
    27 Mar 2024
    Submission under peer review
    19 Feb 2024
    Technical check
    Submission status Date
    Submission passed technical check
    19 Feb 2024
    Submission is under technical check
    18 Feb 2024
    Submission received
    Submission status Date
    Submission received
    18 Feb 2024

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=588890, encodeId=fb3058889093, content=通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/28/a5fe04f5f79e7eaa02a969e1db5d9cfa.jpg, createdBy=aaa45315037, createdName=学海无涯123, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602329, encodeId=6e406023297c, content=请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/b4f0d751268e44e3a8cb4f42e09324f5/2450ad5bc2e449b79c8da57d5f6d1ac1.jpg, createdBy=66d25241559, createdName=147c079dm30(暂无昵称), createdTime=Mon Jun 15 20:02:46 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799576, encodeId=8c71e99576b3, content=投稿8天被拒搞，没有给任何评价，伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/40807ce1b45849feb595a4fd58bc8cce/bae07d646db64f6ba1fc10d2dc5e0bb3.jpg, createdBy=0bdc5296801, createdName=HahaHelloHa, createdTime=Wed Jun 24 16:39:19 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578226, encodeId=85ae5e822622, content=要版面费吗？ <span class="quote">闹闹naonao 2019-10-17 发表::<br>请问需要提供的原始数据都是关于什么实验的呢？ </span><span class="quote">闹闹naonao 2019-10-17 00:00:00 发表:<br>请问需要提供的原始数据都是关于什么实验的呢？ </span>, beContent=闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LZ3kWE6hVO0xjMAhLBocM81brfTB5UBBQ9j4ibbfkFw68aiaqI55zp3WicibzLB7v18d1wSFEYDpsk4qH9ZHFc9Ouw/132, createdBy=0dc52359627, createdName=奔跑的蜗牛222, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587274, encodeId=27f058e27431, content=审稿速度怎么样，一审多久给回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/22/16fe440149131866dcceb2ab3e224120.jpg, createdBy=71912410689, createdName=仰望摩天轮, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588489, encodeId=19fe58848918, content=请问这个杂志如果没送审就被拒的话大概花多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590104, encodeId=1a61590104f1, content=有人知道那个非oa在哪里选吗？为什么我没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde95319819, createdName=2564, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信<br>经验分享：过程还是非常快的，希望期刊后面越来越好<br>Publishing and rights<br>Submission status Date<br>Publishing and rights complete<br>07 May 2024<br>Submission is in publishing and rights<br>15 Apr 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>03 Apr 2024<br>Submission under peer review<br>28 Mar 2024<br>Submission passed technical check<br>28 Mar 2024<br>Revision received<br>27 Mar 2024<br>Submission under peer review<br>19 Feb 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>19 Feb 2024<br>Submission is under technical check<br>18 Feb 2024<br>Submission received<br>Submission status Date<br>Submission received<br>18 Feb 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。<br>Version 1 (private)<br>received 11 Mar, 2024<br><br> Reviews received<br> Received 24 Apr, 2024<br> Reviewers agreed<br> On 27 Mar, 2024<br> Reviewers invited<br> Invitations sent on 21 Mar, 2024<br> Submission checks complete<br> On 13 Mar, 2024<br> Editor assigned<br> On 13 Mar, 2024<br> First submitted to Journal of Cancer Research and Clinical Oncology<br> On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198633, encodeId=5897219863300, content=审稿速度:2.0<br>偏重的研究方向：免疫;肿瘤;生信<br>经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2458147977, createdName=ms7000001719461797, createdTime=Mon Apr 15 16:42:11 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆)]
    2024-04-30 huahaha 来自广西

    捉急的等待，不知道啥时候有结果。。。
    Version 1 (private)
    received 11 Mar, 2024

    Reviews received
    Received 24 Apr, 2024
    Reviewers agreed
    On 27 Mar, 2024
    Reviewers invited
    Invitations sent on 21 Mar, 2024
    Submission checks complete
    On 13 Mar, 2024
    Editor assigned
    On 13 Mar, 2024
    First submitted to Journal of Cancer Research and Clinical Oncology
    On 11 Mar, 2024

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=588890, encodeId=fb3058889093, content=通讯作者的邮箱在投稿系统中显示已注册过，找回密码邮箱确收不到邮件，有战友知道怎么处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/28/a5fe04f5f79e7eaa02a969e1db5d9cfa.jpg, createdBy=aaa45315037, createdName=学海无涯123, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602329, encodeId=6e406023297c, content=请问Cover letter在那上传，我的cover letter没传就提交了。其他流程没有再写cover letter的位置了。求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231127/b4f0d751268e44e3a8cb4f42e09324f5/2450ad5bc2e449b79c8da57d5f6d1ac1.jpg, createdBy=66d25241559, createdName=147c079dm30(暂无昵称), createdTime=Mon Jun 15 20:02:46 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799576, encodeId=8c71e99576b3, content=投稿8天被拒搞，没有给任何评价，伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200807/40807ce1b45849feb595a4fd58bc8cce/bae07d646db64f6ba1fc10d2dc5e0bb3.jpg, createdBy=0bdc5296801, createdName=HahaHelloHa, createdTime=Wed Jun 24 16:39:19 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578226, encodeId=85ae5e822622, content=要版面费吗？ <span class="quote">闹闹naonao 2019-10-17 发表::<br>请问需要提供的原始数据都是关于什么实验的呢？ </span><span class="quote">闹闹naonao 2019-10-17 00:00:00 发表:<br>请问需要提供的原始数据都是关于什么实验的呢？ </span>, beContent=闹闹naonao 2019-10-17 发表:: 请问需要提供的原始数据都是关于什么实验的呢？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LZ3kWE6hVO0xjMAhLBocM81brfTB5UBBQ9j4ibbfkFw68aiaqI55zp3WicibzLB7v18d1wSFEYDpsk4qH9ZHFc9Ouw/132, createdBy=0dc52359627, createdName=奔跑的蜗牛222, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587274, encodeId=27f058e27431, content=审稿速度怎么样，一审多久给回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/22/16fe440149131866dcceb2ab3e224120.jpg, createdBy=71912410689, createdName=仰望摩天轮, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588489, encodeId=19fe58848918, content=请问这个杂志如果没送审就被拒的话大概花多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590104, encodeId=1a61590104f1, content=有人知道那个非oa在哪里选吗？为什么我没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde95319819, createdName=2564, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信<br>经验分享：过程还是非常快的，希望期刊后面越来越好<br>Publishing and rights<br>Submission status Date<br>Publishing and rights complete<br>07 May 2024<br>Submission is in publishing and rights<br>15 Apr 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>03 Apr 2024<br>Submission under peer review<br>28 Mar 2024<br>Submission passed technical check<br>28 Mar 2024<br>Revision received<br>27 Mar 2024<br>Submission under peer review<br>19 Feb 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>19 Feb 2024<br>Submission is under technical check<br>18 Feb 2024<br>Submission received<br>Submission status Date<br>Submission received<br>18 Feb 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。<br>Version 1 (private)<br>received 11 Mar, 2024<br><br> Reviews received<br> Received 24 Apr, 2024<br> Reviewers agreed<br> On 27 Mar, 2024<br> Reviewers invited<br> Invitations sent on 21 Mar, 2024<br> Submission checks complete<br> On 13 Mar, 2024<br> Editor assigned<br> On 13 Mar, 2024<br> First submitted to Journal of Cancer Research and Clinical Oncology<br> On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198633, encodeId=5897219863300, content=审稿速度:2.0<br>偏重的研究方向：免疫;肿瘤;生信<br>经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2458147977, createdName=ms7000001719461797, createdTime=Mon Apr 15 16:42:11 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆)]
    2024-04-15 ms7000001719461797 来自重庆

    审稿速度:2.0
    偏重的研究方向：免疫;肿瘤;生信
    经验分享：4.3提交，到现在状态还是peer review，这个是不是要拒稿的意思啊，要不要催一下呢

    0

共500条页码: 20/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分